Cargando…
Potential of Anti-CMV Immunoglobulin Cytotect CP(®) In Vitro and Ex Vivo in a First-Trimester Placenta Model
Background: Congenital CMV infection is the leading cause of neonatal neurological deficit. We herein studied in vitro and ex vivo the potential of the hyperimmune globulin Cytotect CP(®) (Biotest, Germany) for congenital infection prevention and treatment. Methods: In vitro neutralization assays we...
Autores principales: | Coste Mazeau, Perrine, Jacquet, Chloé, Muller, Clotilde, Courant, Mathis, El Hamel, Chahrazed, Chianea, Thierry, Hantz, Sébastien, Alain, Sophie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030298/ https://www.ncbi.nlm.nih.gov/pubmed/35456746 http://dx.doi.org/10.3390/microorganisms10040694 |
Ejemplares similares
-
Machine learning analysis of pregnancy data enables early identification of a subpopulation of newborns with ASD
por: Caly, Hugues, et al.
Publicado: (2021) -
CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients
por: Schulz, Uwe, et al.
Publicado: (2016) -
Stimulatory Effect of CMV Immunoglobulin on Innate Immunity and on the Immunogenicity of CMV Antigens
por: Deml, Ludwig, et al.
Publicado: (2021) -
Anti-CMV therapy, what next? A systematic review
por: Gourin, Claire, et al.
Publicado: (2023) -
The Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMV
por: Carbone, Javier
Publicado: (2016)